- Home
- SHPH vs SXTP Comparison
SHPH vs SXTP Comparison
Compare SHPH & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHPH
- SXTP
- Stock Information
- Founded
- SHPH 2012
- SXTP 2010
- Country
- SHPH United States
- SXTP United States
- Employees
- SHPH N/A
- SXTP N/A
- Industry
- SHPH Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- SHPH Health Care
- SXTP Health Care
- Exchange
- SHPH Nasdaq
- SXTP Nasdaq
- Market Cap
- SHPH 2.3M
- SXTP 2.7M
- IPO Year
- SHPH 2022
- SXTP 2023
- Fundamental
- Price
- SHPH $0.31
- SXTP $2.95
- Analyst Decision
- SHPH
- SXTP Hold
- Analyst Count
- SHPH 0
- SXTP 1
- Target Price
- SHPH N/A
- SXTP N/A
- AVG Volume (30 Days)
- SHPH 1.8M
- SXTP 4.8M
- Earning Date
- SHPH 05-12-2025
- SXTP 05-14-2025
- Dividend Yield
- SHPH N/A
- SXTP N/A
- EPS Growth
- SHPH N/A
- SXTP N/A
- EPS
- SHPH N/A
- SXTP N/A
- Revenue
- SHPH N/A
- SXTP $681,345.00
- Revenue This Year
- SHPH N/A
- SXTP $95.50
- Revenue Next Year
- SHPH N/A
- SXTP $80.78
- P/E Ratio
- SHPH N/A
- SXTP N/A
- Revenue Growth
- SHPH N/A
- SXTP 168.70
- 52 Week Low
- SHPH $0.23
- SXTP $1.41
- 52 Week High
- SHPH $4.71
- SXTP $36.00
- Technical
- Relative Strength Index (RSI)
- SHPH 39.42
- SXTP 56.45
- Support Level
- SHPH $0.23
- SXTP $2.48
- Resistance Level
- SHPH $0.32
- SXTP $3.45
- Average True Range (ATR)
- SHPH 0.07
- SXTP 0.70
- MACD
- SHPH 0.00
- SXTP 0.02
- Stochastic Oscillator
- SHPH 23.65
- SXTP 47.63
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.